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Abstract
Membrane-embedded prenyltransferases from the UbiA family catalyze the Mg2+-dependent transfer of a hydrophobic
polyprenyl chain onto a variety of acceptor molecules and are involved in the synthesis of molecules that mediate
electron transport, including Vitamin K and Coenzyme Q. In humans, missense mutations to the protein UbiA
prenyltransferase domain-containing 1 (UBIAD1) are responsible for Schnyder crystalline corneal dystrophy, which is a
genetic disease that causes blindness. Mechanistic understanding of this family of enzymes has been hampered by a
lack of three-dimensional structures. We have solved structures of a UBIAD1 homolog from Archaeoglobus fulgidus,
AfUbiA, in an unliganded form and bound to Mg2+ and two different isoprenyl diphosphates. Functional assays on
MenA, a UbiA family member from E. coli, verified the importance of residues involved in Mg2+ and substrate binding.
The structural and functional studies led us to propose a mechanism for the prenyl transfer reaction. Disease-causing
mutations in UBIAD1 are clustered around the active site in AfUbiA, suggesting the mechanism of catalysis is conserved
between the two homologs.
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Introduction
Vitamin K is an essential cofactor required for the posttrans-
lational modification of proteins involved in blood-clotting and
normal bone metabolism. One of the major forms of vitamin K in
humans, menaquinone-4, is produced by cleaving the phytyl
group from dietary phylloquinone to produce menadione, which is
then modified with a polyprenyl group donated from geranylger-
anyl diphosphate (Figure S1). This latter step is catalyzed by the
protein UBIAD1, a member of a family of integral membrane
proteins known collectively as UbiA prenyltransferases [1–3].
Recently, it has also been proposed that UBIAD1 is responsible for
the prenylation of coenzyme Q10 in Golgi membranes [4].
Missense mutations to the UBIAD1 gene are the underlying cause
of the genetic disorder Schnyder corneal dystrophy (SCD), which
causes accumulation of cholesterol and phospholipids in the
cornea of the eye, eventually leading to blindness [5].
Membrane-embedded prenyltransferases belonging to the UbiA
family are found in every branch of life, and are involved in the
biosynthesis of a highly diverse range of molecules, including
respiratory lipoquinones such as ubiquinone and menaquinone
[6–8], prenylated hemes and chlorophylls [9,10], archaeal lipids
[11], numerous prenylated plant flavonoids [12], the antibiotic
aurachin [13], Vitamin E [14,15], and bacterial cell wall
precursors [16]. Although the nature of the prenyl acceptor and
donor vary considerably, reactions catalyzed by UbiA homologs
are Mg2+-dependent and generate pyrophosphate as a leaving
group. A representative reaction, catalyzed by the eponymous E.
coli protein UbiA, involves the cleavage of the C–O bond in
polyprenyl diphosphates of variable length and transfer of the
prenyl chain to the ortho position of the phenol 4-hydroxybenzoic
acid (4HB; Figure 1A). UbiA family members are typically
predicted to contain eight or nine transmembrane helices and
have two characteristic conserved motifs with the consensus
sequences NDXXDXXXD and DXXXD (Figure 1B), often
referred to as the first and second aspartate-rich motifs,
respectively.
To understand the structural basis of UbiA function, we set out
to elucidate the structure of a member of the UbiA family using X-
ray crystallography. The resulting structures of an archaeal
homolog reveal locations of Mg2+ and polyprenyl diphosphate
binding sites, a possible hydrophobic substrate tunnel allowing the
protein to accommodate polyprenyls of variable length, and the
location of a cluster of highly conserved residues forming a
potential catalytic site.
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Results
Fold of AfUbiA
After screening a large number of bacterial and archaeal UbiA
proteins for suitability for crystallization, a homolog from the
extremophile Archaeoglobus fulgidus (AfUbiA) was chosen for
further study based on its stability in detergent (Figure S2A).
Crystals of the selenomethionine-substituted protein diffracted to
3.2 A˚, and the structure was solved by single-wavelength
anomalous dispersion (Table S1). Despite the modest resolution,
assignment of the sequence register was greatly facilitated by the
high quality of the experimentally phased electron density maps,
and by the locations of five selenomethionine residues (Figure
S2B,C). The selenomethionine structure was then used as a
molecular replacement search model for 2.4 and 2.5 A˚ datasets
collected on native AfUbiA crystals, grown in lipidic cubic phase
(LCP) and soaked with either geranyl diphosphate (GPP) or
dimethylallyl diphosphate (DMAPP) prior to freezing (Table S1,
Figure S2D). The final models for the two substrate-bound
structures contain four AfUbiA molecules in the asymmetric unit,
with one molecule of GPP or DMAPP and two Mg2+ per protein
chain. Comparison of the detergent and LCP crystal forms shows
that none of the interaction surfaces between neighboring
protomers are conserved between the different lattices, and so
the protein is likely a monomer in the membrane (Figure S2E).
The AfUbiA structure contains a total of nine transmembrane
helices, with the N and C termini emerging on opposite sides of
the membrane (Figure 1C). Based on the distribution of positive
and negative charges in the soluble loops, the N terminus of the
protein is probably oriented towards the cytoplasm and the C
terminus to the extracellular side [17]. This assignment is also
consistent with the experimentally determined orientation of E.
coli UbiA [18]. The first eight helices can be grouped into two
bundles of four helices each (Figure 1D). The loops connecting the
transmembrane helices are short, with the exception of the
cytoplasmic loops connecting TM2 and 3 (L2–3) and TM6 and 7
(L6–7), which are both over 25 and 18 residues in length,
respectively, and contain short helical regions. The two conserved
aspartate-rich motifs are both positioned on the cytoplasmic side of
the protein, between the C-terminal ends of TM2 and TM6 and
the L2–3 and L6–7 loops (Figure 1E). Interestingly, the conserved
motifs as well as the large cytoplasmic loops that follow them are at
equivalent positions in the two four-helix bundles. Closer
examination of the two bundles reveals that they are structurally
Figure 1. The UbiA fold. (A) A representative reaction catalyzed by UbiA family members. Polyprenyl is transferred from diphosphate to 4HB to
form 3-polyprenyl-4-hydroxybenzoate, a precursor to ubiquinone. The square brackets denote a single five-carbon prenyl unit. (B) The two conserved
aspartate-rich motifs characteristic of the UbiA family. Residue numbers correspond to the Archaeoglobus fulgidus UbiA sequence. Ec, Escherichia coli;
Sc, Saccharomyces cerevisiae; Hs, Homo sapiens; Af, Archaeoglobus fulgidus. (C) Topology diagram of AfUbiA, with the transmembrane helices colored
in pairs of equivalent helices in the four-helix bundles. Dashed lines indicate the region of L2–3 that is disordered in the SeMet crystal structure. (D)
Cartoon representation of the AfUbiA structure viewed from within the plane of the membrane (left) and from the extracellular side of the membrane
(right). The transmembrane helices are colored according to the same scheme as in panel (C). Orange arrows indicate the two pseudosymmetric
bundles. (E) Magnified stereo view of the boxed area in panel (D), showing residues from aspartate-rich Motif I and II as sticks.
doi:10.1371/journal.pbio.1001911.g001
Author Summary
The biosynthesis of Vitamin K and Coenzyme Q requires
the transfer of a long, hydrophobic moiety known as an
isoprenyl onto an aromatic acceptor compound. This
process is catalyzed by a family of proteins known as the
UbiA proteins, which are embedded in the hydrophobic
environment of cell membranes. To understand how the
prenyltransfer reaction is carried out, we solved the three-
dimensional structure of a member of the UbiA family by
X-ray crystallography. This structure reveals how magne-
sium ions and the prenyl substrate are bound within a
sealed amphipathic chamber inside the protein and
suggests how the reaction intermediate may be stabilized
by the protein and protected from the solvent. Functional
studies carried out on another member of the UbiA family,
as well as comparison to known disease-causing mutations
in the human homolog UBIAD1, demonstrate that the
residues involved in this process are conserved across the
UbiA family.
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homologous and can be superposed by a twofold pseudosymmetry
axis running through the center of the protein perpendicular to the
bilayer (Figure 1D, Figure S3). This raises the possibility that the
UbiA fold may have arisen from the duplication of an ancient
four-helix, dimeric protein.
The crystal structure of another archaeal UbiA homolog from
Aeropyrum pernix (ApUbiA) was recently reported with a
resolution of 3.6 A˚ [19]. The overall fold of AfUbiA is similar to
that seen in ApUbiA, but there are differences in the location and
coordination of Mg2+ and substrate (detailed in the section
‘‘Differences between the AfUbiA and ApUbiA crystal struc-
tures’’). Both UbiA family members resemble proteins belonging
to the isoprenoid synthase superfamily [20], and in particular,
those members that catalyze the synthesis of all-trans polyprenyls
by repeated addition of isopentenyl pyrophosphate (IPP; Figure
S1), the trans-IPPSs. These enzymes are also Mg2+-dependent and
contain similar aspartate-rich motifs. Although any sequence
identity between the soluble and transmembrane families is
negligible, comparison of AfUbiA to the trans-IPPS farnesyl
diphosphate synthase (FPPS) from E. coli (Figure S4A–B) [21]
reveals that the two four-helix bundles comprising helices 1–8 in
AfUbiA and 2–9 in FPPS are superposable. TM9 in AfUbiA and
the first helix in the trans-IPPS fold have no equivalent in the other
family. Nevertheless, despite their structural similarity, examina-
tion of the distribution of charged residues on the two enzymes
clearly reveals their distinct identities as soluble and transmem-
brane proteins (Figure S4C–D).
Architecture of the Central Cavity and Substrate-Binding
Site
The bound isoprenyl-diphosphates and Mg2+ are located in a
large cavity at the interface between the four-helix bundles near
the cytoplasmic side, which is partly closed off from the solvent by
the L2–3 and L6–7 loops (Figure 2A). Interestingly, in the
unliganded structure, a 13-residue long region of the L2–3 loop is
disordered, leaving this cavity widely accessible to the solvent,
whereas all but four residues become resolved in the GPP-bound
structure. In the DMAPP-bound structure, the entire loop is
resolved and completely occludes the cavity from the solvent
(Figure S5A,B). This difference may be attributed to the lower
resolution of the unliganded structure, however, as the substrate in
the DMAPP-bound structure is occluded from the cytoplasm, a
more likely possibility is that substrate binding induces conforma-
tional changes in the L2–3 loop and thus seals off the active site.
Near the cytoplasm, the central cavity is broad and is lined with
polar and charged residues, including the aspartate-rich motifs and
many of the other residues that are most conserved across the
UbiA family (Figure 2B). The cavity becomes more hydrophobic
and tapers into a narrow tunnel as it extends deeper into the
transmembrane region of the protein. Approximately halfway into
the bilayer, the tunnel bends sharply and forms a fenestration in
the side of the protein that opens into the bilayer (Figure 2C). This
tunnel could offer a possible explanation for how UbiA family
members utilize prenyl donors of varying lengths, which range
from DMAPP (C5) [22] to dodecaprenyl phosphate (C60) [16].
The latter substrate approaches 60 A˚ in length in a fully extended
conformation; in comparison, the membrane-spanning region of
AfUbiA is less than 40 A˚. The hydrophobic tunnel in AfUbiA
could potentially accommodate up to six prenyl units, and even
longer polyprenyls could bind to the protein by extending directly
into the hydrophobic core of the bilayer.
In the GPP-bound structure, the substrate is located in the
central cavity with its diphosphate positioned between the two
aspartate-rich motifs (Figure 3A,B). Two electron densities are also
visible on either side of the diphosphate that likely correspond to
Mg2+. This observation is consistent with data showing that the
activity of UbiA family members is Mg2+-dependent, as well as
extensive mutagenesis experiments, confirming the importance of
the two motifs for activity in E. coli UbiA [23] and other homologs
[13,24]. The two Mg2+ are coordinated by N68 and D72 in the
first aspartate-rich motif and D198 and D202 in the second
aspartate-rich motif (Figure 3A). The conserved aspartate D76 is
too far away to bind directly to Mg2+ in the first motif, but could
interact indirectly by stabilizing a water molecule coordinating the
ion. The diphosphate group of GPP is stabilized by Mg2+ in the
first motif, which bridges two oxygens with coordination distances
of 2.3 and 2.6 A˚. In contrast to the first motif, the Mg2+ bound to
the second motif is 3.5–4.0 A˚ away from the diphosphate, which is
significantly farther than the expected coordination distance of
2.0–2.3 A˚. Additional interactions between the protein and GPP
oxygens are provided by the basic residues R22 and K146. The
GPP molecule is slightly kinked after the diphosphate, so that the
isoprenyl tail extends along the wall of the cavity close to highly
conserved residues on TM2, 4, and 5. In particular, the C–O bond
cleaved in the prenyltransfer reaction is positioned near a cluster of
conserved polar residues including N68, Y139, and S140
(Figure 3B). The geometry of the Mg2+ and substrate binding
sites in the DMAPP-bound structure is similar (Figure S5C,D).
Figure 2. The substrate-binding cavity and possible substrate
tunnel. (A) The solvent-accessible surface of the central cavity in the
GPP-bound AfUbiA structure is shown as a blue mesh. Helix TM9 is
highlighted in pink. (B) A ribbon representation of the AfUbiA structure
in which the thickness and color of the ribbon indicate the degree of
conservation. Highly conserved residues are thicker and colored dark
purple; poorly conserved residues are thinner and colored teal. Residues
colored yellow were not included in the multiple sequence alignment
used to calculate the conservation scores. GPP and Mg2+ are shown in
green. (C) Cutaway view of the central cavity and putative substrate
tunnel from two perpendicular directions in the plane of the
membrane, with the extracellular side on top. The molecule of GPP is
shown as sticks. The pink arrow indicates a hydrophobic tunnel that
opens into the membrane bilayer.
doi:10.1371/journal.pbio.1001911.g002
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We used two approaches to verify the interactions between the
bound substrate, ions, and protein in our crystal structure. First, to
confirm the Mg2+ binding sites, we co-crystallized the protein with
Cd2+ (Table S1). Two strong electron densities consistent with
Cd2+ appear coordinated by the aspartate-rich motifs, which align
well to the Mg2+ locations in the GPP-bound structure (Figure S6).
Second, we used isothermal titration calorimetry (ITC) to measure
the Mg2+ dependence of GPP binding to AfUbiA. In the presence
of 2 mM MgCl2, GPP binds to AfUbiA with a KD of 3.260.1 mM
(Figure 3C). However, when 1 mM EDTA was added instead of
MgCl2, no GPP binding was observed (Figure 3D). Residues N68,
D72, D198, and D202 from the two aspartate-rich motifs, as well
as the basic residues R22 and K146, were then mutated to alanine
to test their contribution to Mg2+-dependent GPP binding
(Figure 3E, Figure S7). Mutations to all six residues had
pronounced effects on binding of GPP to AfUbiA. Four of the
mutations completely abolished GPP binding, whereas the effects
of the D198A and D202A mutations were comparatively mild,
Figure 3. Substrate binding and active site. (A) Stereo view of the GPP binding site, viewed from the cytoplasmic side of the membrane. Two
Mg2+ atoms (green spheres) and a GPP molecule are shown in the binding site. Residues that potentially bind to Mg2+ and the diphosphate are
labeled. (B) Stereo view of the active site from within the plane of the membrane. Conserved residues proposed to stabilize the intermediate state are
labeled. The green mesh in both figures corresponds to Fo-Fc density contoured at 3.0 s. (C and D) Binding of GPP to detergent-solubilized AfUbiA
measured by ITC. Heats from successive injections of GPP were measured in the presence of 2 mM MgCl2 (C) or 1 mM EDTA (D). Right panel in (C)
shows the fit to a one-site model. (E) Table of thermodynamic values for GPP binding to WT and mutant AfUbiA measured by ITC. KD, DH, and n were
obtained by fitting a binding isotherm described in the Methods section. The thermodynamic relation DG =DH2TDS was used to calculate 2TDS at
25uC with errors propagated. ‘‘N.D.’’ indicates no binding detected. Each value is the mean and s.e.m. of three ITC experiments.
doi:10.1371/journal.pbio.1001911.g003
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increasing the KD by 45- and 21-fold, respectively. This is
consistent with the observation that the distance between the Mg2+
bound to the second aspartate-rich motif and the GPP diphos-
phate is outside of the typical coordination distance range.
Differences Between the AfUbiA and ApUbiA Crystal
Structures
There are notable differences in the shape of the substrate-
binding cavity and in the organization of the active sites of the
AfUbiA and ApUbiA structures. The central cavity in ApUbiA is
smaller than in AfUbiA, largely because ApUbiA lacks the long
hydrophobic tunnel and second opening observed in AfUbiA. For
the ApUbiA structure, it was proposed that longer prenyl chains
may extend out of the protein via its single entrance to the central
cavity, which is closer to the membrane interface than in AfUbiA.
This mechanism of accommodating long prenyl chains is not likely
for the current AfUbiA structure, because although the cytoplas-
mic opening exists in unliganded AfUbiA, it is completely closed in
the DMAPP-bound structure (Figure S5B).
In both structures, the bound Mg2+ and the diphosphate moiety
are located in the central cavity between the two conserved
aspartate-rich motifs; however, interactions between the protein
and ligands are different (Figure 4). Although two bound Mg2+
were modeled in both structures, in the current AfUbiA structure,
N68, D72, D198, and D202 directly coordinate the Mg2+, while in
the ApUbiA structure all the corresponding residues are .3.4 A˚
away from Mg2+. These four residues were demonstrated to be
important for Mg2+-dependent GPP binding according to our ITC
data (Figure 3E). The differences in Mg2+ location and coordina-
tion between the two structures are likely attributable to the
significantly lower resolution (3.6 A˚) of the ApUbiA structure.
4HB was also modeled into the ApUbiA structure, although
there is currently no direct biochemical evidence that it can act as
a prenyl acceptor for ApUbiA. This proposed 4HB binding site is
unlikely to hold the prenyl acceptor in the current AfUbiA
structure, as its position clashes with the location of the geranyl
moiety. We were also unable to detect binding of 4HB to AfUbiA
by ITC.
Conservation with Other UbiA Family Members and
Implications for the Catalytic Mechanism
Although two crystal structures are available now for the UbiA
family of proteins, both AfUbiA and ApUbiA are from archaeal
thermophiles and enzymatic activity has not been demonstrated
for either of the proteins. To understand the relevance of the
AfUbiA structure to other UbiA family members, we mutated a
number of residues on the E. coli MenA homolog (EcMenA) that
are equivalent to key active site residues in AfUbiA (Figure 5A,
Figure 5B). EcMenA catalyzes the transfer of a prenyl chain onto
1,4-dihydroxy 2-naphthoic acid (DHNA) to produce the mena-
quinone precursor demethylmenaquinone. Two independent
functional assays were used to measure the effects of mutations
on EcMenA: an in vivo genetic complementation assay in which
growth under anaerobic conditions was measured in an menA2 E.
coli strain [25] transformed with WT or mutant EcMenA
(Figure 5C), and an in vitro assay measuring prenyltransferase
activity with purified membranes from E. coli cells overexpressing
WT or mutant EcMenA (Figure 5D, Figure S8). For both assays,
mutations to the equivalents of N68 and D72 in the first aspartate-
rich motif and D198 and D202 in the second motif resulted in
total or near-total loss of function. Mutation of the highly
conserved tyrosine (Y139 in AfUbiA) near the C–O bond also
resulted in loss of function.
Functional data for eukaryotic UbiA homologs are currently
scarce, but missense mutations to 19 different residues on human
UBIAD1 are known to cause SCD [5,26–35]. Of these, three align
to insertions not present on AfUbiA (Figure 5A). As shown in
Figure 5E, the remaining 16 mutated residues all map to the
region around the putative active site at the cytoplasmic end of the
cavity. The residues Y174 and T175 on human UBIAD1 are
equivalent to Y139 and S140, which belong to the cluster of polar
residues on TM2 and TM4 likely important for catalysis; the
residues A97 and G98 (F63 and S64 on AfUbiA) pack into the
interface between TM2 and TM4 near this site (Figure 5F).
Residues N102, K181, D236, and D240 on UBIAD1 are
homologous to N68, K146, D198, and D202, which form part
of the Mg2+/diphosphate binding site (Figure 3A). Residues 112,
118, 119, 121, and 122 on UBIAD1 align to residues 78, 90, 91,
93, and 94 on the highly mobile L2–3 loop of AfUbiA, which
changes conformation upon substrate binding in AfUbiA.
Potential functions for G177, G186, and L188 (P142, D152, and
I154 on AfUbiA) are less evident, but all three residues are located
in close proximity to the proposed active site.
Overall, the above experiments on EcMenA and the mapping
of UBIAD1 mutations onto the AfUbiA structure suggest that the
fold and location of substrate-binding sites are conserved across
the UbiA family, and that the mechanism of the prenyltransfer
reaction is conserved as well. Although this mechanism is currently
unknown, possible clues may be found by comparison to the
soluble trans-IPPS proteins. In addition to sharing a fold with the
UbiA homologs, the two protein families also exhibit similarities in
the architecture of their active sites. The structure of E. coli FPPS
bound to IPP and a thio- analog of the prenyl donor, thioDMAPP,
is representative of available structures of trans-IPPS ternary
complexes (Figure S9) [21]. Like AfUbiA, members of the trans-
IPPS family contain two signature acidic motifs, which both
contain the conserved sequence DDXXD [36] and which
coordinate Mg2+ atoms that stabilize the diphosphate on the
prenyl donor. In trans-IPPS proteins, the reaction is believed to
proceed via a three-stage ionization–condensation–elimination
mechanism [37], involving a carbocation intermediate in the
allylic site that is stabilized by the liberated diphosphate as well as
interactions with nearby polar side chains [21,38]. Given the
Figure 4. Comparison of the AfUbiA and ApUbiA active sites. (A
and B) Interactions between Mg2+, GPP/GSPP, and residues in the first
and second aspartate-rich motifs are shown for (A) AfUbiA and (B)
ApUbiA (PDB accession 4OD5). All interaction distances of 3.0 A˚ or less
are marked.
doi:10.1371/journal.pbio.1001911.g004
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Figure 5. Conservation of active site residues across the UbiA family. (A) A sequence alignment of AfUbiA, human UBIAD1, and EcMenA.
Residues currently known to be mutated in SCD patients are highlighted in pink, red, or blue in the AfUbiA and HsUBIAD1 sequences. Red indicates
mutated residues that are identical between the two proteins; blue indicates residues that align with gaps in the AfUbiA sequence. Green boxes
indicate locations of residues that were mutated in the EcMenA functional assays. The colored bars above the alignment indicate locations of
transmembrane helices in the AfUbiA crystal structure. (B) The locations of the active site residues marked with green boxes in panel (A) are shown
relative to bound Mg2+ and GPP in the AfUbiA structure. Black labels correspond to residue numbers in the AfUbiA structure, green labels to the
equivalent residues in EcMenA. (C) A menA2 E. coli strain was transformed with plasmids containing either WT or mutant EcMenA, and grown in
suspension cultures in an anaerobic chamber. The optical densities at 600 nm were measured after 24 h. Cells transformed with an unrelated protein
(TrkH) were used as the negative control. Error bars are standard deviations of three experiments. Data used to calculate the bar graphs are shown in
Table S2. (D) Membranes were purified from E. coli overexpressing WT or mutant EcMenA and incubated at 37uC for 10 min with 2 mM DHNA, 1 mM
GPP, and 5 mM MgCl2. Product formation was measured by HPLC and is shown as a percentage of the activity for WT EcMenA. Membranes from cells
overexpressing EcUbiA, which is selective for 4HB as the prenyl acceptor, were used as a negative control. Error bars are standard deviations of three
experiments. Data used to calculate the bar graphs are shown in Table S3. (E) Residues currently known to be mutated in SCD patients are shown as
spheres on the structure of AfUbiA. (F) The same residues are shown as sticks in a closer view of the substrate-binding cavity from within the plane of
the membrane (left) and from the intracellular side (right).
doi:10.1371/journal.pbio.1001911.g005
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structural and functional similarity between AfUbiA and the trans-
IPPS proteins, it is possible that this catalytic mechanism is shared
with homologs of the UbiA family (Figure 6).
In the GPP- and DMAPP-bound structures, C-C bond
formation would occur near a triad of three polar side chains:
N68 from the first aspartate-rich motif, and Y139 and S140 on
TM4 (Figure 3B). Interestingly, the tyrosine is the single most
highly conserved residue in the UbiA family, present in 97% of the
more than 10,000 UbiA sequences currently in the Pfam database
[39]. Mutation of this residue in both EcMenA (Figure 5C,D) and
EcUbiA [19] results in a loss of function. The near-universal
conservation of the tyrosine residue implies that this site is involved
in a function that is shared among all the different branches of the
UbiA family, regardless of the nature of the highly variable prenyl
acceptor. We therefore propose that this site could be involved in
stabilizing the carbocation intermediate on the prenyl donor after
cleavage of the pyrophosphate leaving group, possibly by cation–p
interactions with Y139. A similar role for active site tyrosine
residues has been proposed for the structurally unrelated aromatic
prenyltransferases DMATS and CloQ [40–42].
Discussion
We have described the structure of an archaeal member of the
UbiA family of membrane-embedded prenyltransferases. The
substrate-bound structures reveal that the diphosphate group
interacts with arginine and lysine side chains as well as Mg2+
coordinated by conserved aspartate-rich motifs. Although short
prenyl donors containing only one or two prenyl units were chosen
for crystallization due to their higher solubility in water, the
structure reveals a long, narrow cavity that opens into the
membrane and could allow the protein to bind significantly longer
polyprenyl chains. Due in part to its low homology with UbiA
family members of known function, we were unable to identify the
natural prenyl-accepting substrate of AfUbiA. Nonetheless, the
EcMenA functional assays using mutations designed with the
AfUbiA structure, as well as the clustering of SCD-causing
mutations around conserved residues in the substrate-binding
cavity of AfUbiA, suggest that the fold and key aspects of the
catalytic mechanism may be conserved between these distantly
related homologs and that AfUbiA is a useful structural model for
understanding UbiA family prenyltransferases.
One curious feature of the substrate-bound structures is that the
Mg2+ bound to the second conserved motif is out of range for
coordination of the prenyl donor, and yet the functional data for
EcMenA indicate that the residues coordinating this Mg2+ are
critical for function. One possible explanation is that when the
protein is bound to Mg2+ and the isoprenyl diphosphate only, the
substrate is coordinated by only one Mg2+ in order to prevent
reaction of the isoprenyl diphosphate with water in the absence of
the prenyl acceptor, as interactions with one Mg2+ may not be
sufficient to induce spontaneous cleavage of the C–O bond.
Binding of the prenyl acceptor would then induce a conforma-
tional change to bring the Mg2+ bound to the second conserved
motif within coordination distance of the diphosphate and exclude
water from the cavity. Another possibility has also been proposed
based on homology models of E. coli UbiA [23], that UbiA
homologs stabilize the diphosphate via a single Mg2+ bound to
only one of the two aspartate-rich motifs and that the other motif
activates the phenolic substrate by abstracting a proton. Resolu-
tion of the issue will likely require a structure of the full ternary
complex.
In the structurally related trans-IPPS FPPS, comparisons of the
ternary complex and apo-structure show that the enzyme under-
goes a conformational change upon binding substrate; in
particular, the loops corresponding to L2–3 and L6–7 in UbiA
close over the active site to occlude it from the solvent [21]. The
unliganded and substrate-bound AfUbiA structures show similar
behavior, in that a region of the L2–3 loop undergoes a disordered
to ordered transition upon substrate binding. The prenyl acceptor
could therefore enter the cavity through an opening formed by
fluctuations in the L2–3 loop, which would then be stabilized in
the closed conformation. Although short polyprenyl diphosphates
like GPP could also enter the substrate-binding cavity via the
opening to the cytoplasm, longer polyprenyl diphosphates have
poor solubility in water and likely partition into the lipid bilayer,
and therefore may bind to the protein laterally from within the
membrane. Because it seems implausible that the negatively
charged diphosphate group enters the core of the bilayer and
threads into the hydrophobic tunnel, the protein may undergo a
conformational change to allow the polyprenyl substrate access to
the substrate binding cavity. In the crystal structure, one wall of
the substrate tunnel is formed by TM9, whose removal leaves the
central cavity completely exposed to the bilayer (Figure 2A). A
slight movement of this loosely packed helix could potentially
suffice to allow substrates to enter the binding site and allow
release of the product as well.
Methods
Cloning and Overexpression of AfUbiA
Fifty-two bacterial and archaeal UbiA homologs were cloned
and tested for expression [43]. A UbiA gene from Archaeoglobus
fulgidus DSM 4304 (GenBank AAB89594.1) was identified as the
Figure 6. The proposed UbiA prenyltransferase reaction mechanism. Schematic showing a potential three-stage ionization (i), condensation
(ii), and elimination (iii) reaction mechanism for prenyl transfer, with key conserved residues on the enzyme highlighted. The prenyl acceptor shown is
the proposed substrate for UBIAD1, the reduced form of menadione (2-methyl-1,4-dihydroxynaphthoquinol); residue numbers are for AfUbiA and
human UBIAD1 (in parentheses).
doi:10.1371/journal.pbio.1001911.g006
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most promising candidate for crystallization trials. The AfUbiA
gene was cloned into a modified pET vector (Novagen) with an N-
terminal polyhistidine tag. For large-scale purification of native
AfUbiA, the plasmid was transformed into BL21 (DE3) cells. For
expression of the native protein, the transformants were grown in
Luria broth supplemented with 100 mg/l Kanamycin at 37uC
until OD600 reached 1.0 and induced with 0.5 mM isopropyl b-D-
1-thiogalactopyranoside (IPTG) at 20uC for 15 h. For expression
of selenomethionine-incorporated proteins, the cells were grown in
minimal medium containing 32.2 mM K2HPO4, 11.7 mM
KH2PO4, 6 mM (NH4)2SO4, 0.68 mM Na Citrate, 0.17 mM
Mg2SO4, 32 mM glucose, 0.008% (w/v) alanine, arginine,
aspartic acid, asparagine, cysteine, glutamic acid, glycine, histi-
dine, proline, serine, tryptophan, glutamine, tyrosine, 0.02% (w/v)
isoleucine, leucine, lysine, phenylalanine, threonine, valine,
25 mg/l L-selenium-methionine, 32 mg/l thiamine, and 32 mg/
l thymine, and induced when OD600 reached 0.6.
Purification and Crystallization of AfUbiA
Cell membranes were solubilized with 40 mM n-decyl-b-D-
maltoside (DM, Anatrace), and the His-tagged protein was
purified with TALON Metal Affinity Resin (Clontech Inc.). After
removal of the N-terminal His-tag with TEV protease, the native
protein was subjected to size exclusion chromatography with a
Superdex 200 10/300 GL column (GE Health Sciences) pre-
equilibrated in a buffer of 150 mM NaCl, 20 mM HEPES,
pH 7.5, 5 mM b-mercaptoethanol (bME), and 40 mM n-Octyl-b-
D-Glucopyranoside (OG, Affymetrix). The protein was concen-
trated to 10 mg/ml as approximated by ultraviolet absorbance.
The selenomethionine-incorporated protein was purified by the
same procedure. AfUbiA for the ITC assay was also purified with
the same protocol except that 4 mM of DM was used in place of
OG in the size-exclusion chromatography buffer.
Selenomethionine-incorporated AfUbiA crystals were obtained
in mother liquor containing 12.5% PEG20000, 100 mM MES
buffer, pH 6.7. To obtain LCP crystals, the purified AfUbiA
protein was concentrated to around 35 mg/ml as approximated
by ultraviolet absorbance at 280 nm and mixed with monoolein
(1-oleoyl-rac-glycerol; Sigma Aldrich) at a 2:3 ratio (protein/lipid,
w/w) using the twin-syringe mixing method [44]. The protein/
lipid mixture was dispensed manually in 30–50 nl drops onto 96-
well glass Laminex plates (Molecular Dimensions) and overlaid
with 1.7 ml precipitant solution per drop. Crystals reached full size
within 2 wk at 20uC in 34% (w/v) PEG400, 0.1 M Tris-HCl
pH 8.2, 0.1 M NaCl, and 0.1 M MgCl2. Before harvest, crystals
were soaked in 1 mM GPP or 1 mM DMAPP. The LCP crystals
were flash frozen in liquid nitrogen without additional cryopro-
tectant. Crystals of native AfUbiA bound to Cd2+ were obtained in
30% PEG 550 MME, 100 mM MES buffer, pH 6.6, 5 mM
MgCl2, and 100 mM CdCl2. Before flash-freezing in liquid
nitrogen, these crystals were cryoprotected in serial mother liquor
solutions containing 5%–25% (v/v) glycerol.
Structure Solution and Analysis
X-ray data were collected at beamlines X29 at the National
Synchrotron Light Source and 24ID-C and 24ID-E at the
Advanced Photon Source. A data set collected on a selenomethi-
onine crystal was processed and scaled with a 3.2 A˚ cutoff using
HKL2000 [45]. Four selenium sites were located with phenix.hyss
[46], and phases and a partial polyalanine model were obtained
with phenix.autosol [47]. The locations of the selenium atoms and
clear side chain densities from aromatic side chains in the
experimental maps (Figure S2B,C) were used to manually assign
the sequence register, and the structure was refined through
iterative rounds of manual model building and automated
reciprocal-space refinement using Coot [48] and phenix.refine.
The final refined model has R and Rfree values of 25.1% and
28.9%, respectively, and contains residues 15–73 and 86–300 of
one UbiA monomer and one molecule of OG, which was used to
solubilize the protein. The native GPP-bound and DMAPP-bound
structures were solved by molecular replacement using the
selenomethionine structure as a search model and refined with
phenix.refine using strong NCS restraints that were gradually
relaxed over the course of refinement. The final structures each
contained four molecules of AfUbiA, 8 Mg2+, and 4 molecules of
GPP or DMAPP. The Cd2+-bound structure was solved by a
similar protocol. The final Cd2+-bound structure contained two
molecules of AfUbiA in the asymmetric unit and eight Cd2+ ions.
In the SeMet, GPP- and DMAPP-bound structures, the putative
substrate tunnel is partly occupied by a strong, tubular, nonprotein
electron density (Figure S10); however, the resolutions do not
allow a definitive identification of this ligand. The GPP-bound,
DMAPP-bound, SeMet, and Cd2+-bound structures have been
deposited in the PDB under the accession codes 4TQ3, 4TQ4,
4TQ5, and 4TQ6, respectively.
Chain A in the GPP-bound structure had the highest quality
2Fo-Fc density, as well as the lowest average B-factors of the four
protein chains in the asymmetric unit, and was therefore used to
generate figures and for distance measurements unless otherwise
noted. All structure figures were made using PyMol (Schro¨dinger).
Sequence conservation scores in Figure 2B were calculated with
the ConSurf server [49], using the seed sequences for the UbiA
family from Pfam [39] for the multiple sequence alignment. The
alignment of AfUbiA, EcMenA, and human UBIAD1 used for
Figure 5A was generated by aligning the sequences to the Hidden
Markov Model profile for the UbiA family in Pfam.
ITC of GPP Binding to AfUbiA
The ITC buffer comprised 20 mM HEPES (pH 7.5), 150 mM
NaCl, and 4 mM n-decyl-b-D-maltopyranoside (DM). The
chamber contained ITC buffer plus 50 mM AfUbiA and either
2 mM MgCl2 or 1 mM EDTA. The syringe contained ITC buffer
plus 0.6 mM geranyl pyrophosphate (GPP) and either 2 mM
MgCl2 or 1 mM EDTA, whichever matches the chamber
condition. The buffer-alone control had no AfUbiA in the
chamber. For experiments with mutant proteins, 50 mM AfUbiA
mutant proteins were in ITC buffer containing 2 mM MgCl2 with
either 0.6 mM GPP (for R22A, N68A, D72A, K146A) or 2 mM
GPP (for D198A and D202A) in the syringe. Solutions were
filtered and centrifuged at 18,0006 g for 5 min prior to the
experiments. All binding measurements were performed using a
MicroCal iTC200 System (GE Healthcare) at a constant
temperature of 25uC. For experiments with apparent binding,
thermograms were processed and fit in Origin to a one-site model
to obtain n (stoichiometry), K (association constant), and DH
(enthalpy). The dissociation constant (KD) was calculated from
KD = 1/K, and DS was calculated from DG =DH2TDS. All
experiments were performed at least three times.
MenA Complementation Assay
The menA-deficient E. coli strain AN67 [25], which exhibits a
grow defect under anaerobic conditions, was obtained from the
Coli Genetic Stock Center and transformed with a pET31 plasmid
containing WT and mutant EcMenA genes, or an unrelated
protein (the TrkH potassium transporter from Campylobacter
jejuni) as a negative control. The transformants were grown
aerobically in Luria broth to an optical density of
1.0%60.05%, supplemented with 20% glycerol, flash frozen,
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and stored at 280uC. The EcMenA genetic rescue experiments
were carried out using a protocol adapted from Suvarna et al. [7].
The 10 mL cultures of a glycerol/trimethylamine N-oxide
minimal media [50] containing 0.5 mM IPTG and 0.1 mg/mL
ampicillin were inoculated with 10 ml of the glycerol stocks and
then incubated in an anaerobic chamber at 37uC. At 24 h
postinoculation, OD600 was measured for each culture. Values
shown in Figure 5C are averages for three experiments.
Prenyltransferase Activity Assay
Purified E. coli membranes were prepared by harvesting 1 l of
cells overexpressing WT and mutant EcMenA, grown to 1 OD as
described for AfUbiA. The proteins were expressed as SUMO
fusion proteins to increase yield. The cell pellets were resuspended
in 20 ml lysis buffer (20 mM Hepes pH 7.5, 150 mM NaCl,
2 mM bME, 5 mM MgCl2, 1 mM PMSF, 25 mg/ml DnaseI).
After breaking the cells by sonication, the cell lysates were
centrifuged for 30 min at 3,0006g and 4uC. The supernatant was
then transferred to clean centrifuge tubes and centrifuged a second
time for 60 min at 100,0006 g and 4uC. The membrane pellet
was resuspended in 3 ml 50 mM Tris pH 7.5, flash frozen, and
stored at 280uC. Overexpression of WT and mutant SUMO-
EcMenA was verified by running 0.5 ml of the membrane
suspension before and after a 30 min digestion with 1 mg SUMO
protease on an SDS-PAGE gel (Figure S8C). In addition to the
WT and mutant EcMenA proteins, membrane fractions were
prepared in the same manner for cells expressing SUMO-EcUbiA,
which does not utilize DHNA as a prenyl acceptor, for the
negative control.
For the enzymatic assay, 30 ml reaction mixtures were prepared
with the following components: 3 ml purified membrane fractions,
2 mM DHNA, 1 mM GPP, 5 mM MgCl2, 5 mM bME, 5%
acetonitrile (ACN), and 50 mM Tris pH 7.5. The reaction
mixtures were incubated for 10 min at 37uC, quenched with the
addition of 2% formic acid, and extracted with 10 volumes of
chloroform. The chloroform was dried under air and the residue
resuspended in 60 ml 65% ACN/35% 50 mM Tris pH 7.5 in
dH2O. The resulting samples were then separated using reverse
phase HPLC with a gradient of 65%–75% ACN for the mobile
phase. Enzyme activity was quantified as the area of the product
peak, normalized by the activity for the WT protein. Values shown
in Figure 5D are averages for three experiments.
Supporting Information
Figure S1 Metabolic pathway for the conversion of phylloqui-
none to menaquinone-4. FPPS, farnesyl diphosphate synthase;
GGPPS, geranylgeranyl diphosphate synthase. The enzyme
responsible for cleaving the phytyl tail from phylloquinone is not
currently known.
(TIF)
Figure S2 Purification and structure solution of Archaeoglobus
fulgidus UbiA. (A) Elution profile of AfUbiA solubilized in the
detergent b-octylglucoside from a size-exclusion column. (B) The
structure of AfUbiA overlaid with electron density from the
anomalous difference map contoured at 4 s (orange mesh).
Selenium atoms from selenomethionine residues are shown as blue
spheres. (C) A representative region of the electron density map
calculated from the experimental phases, after solvent flattening
and density modification, for the SeMet/detergent crystal used for
phasing. The blue mesh corresponds to a contour level of 1.5 s.
(D) The same region in the 2Fo-Fc maps in the GPP-bound native
structure, contoured at 1.5 s. (E) One cross-section of the crystal
lattice in the P3112 detergent crystals (left) and the P21 LCP
crystals (right). Molecules from one asymmetric unit in each are
colored red.
(TIF)
Figure S3 Pseudosymmetry in the UbiA fold. (A) Transmem-
brane helices TM1–4 (left) and TM5–8 (right) of AfUbiA. (B)
TM1–4 and TM5–8 are shown superposed on each other from
two different orientations.
(TIF)
Figure S4 Structural similarity to soluble isoprenoid synthases.
(A–B) The structures of AfUbiA (A) and an FPPS from E. coli
(PDB accession code 1RQI) (B) are shown as cartoon represen-
tations from the same orientation. For consistency with AfUbiA,
the helices in 1RQI are numbered 0–8 and the helices in both
proteins are colored according to the same scheme as in Figure 1C.
(C–D) The structures of AfUbiA (C) and 1RQI (D) are shown as
cartoon representations from the same orientation. All histidine,
lysine, and arginine residues in both structures are shown as blue
spheres, and all aspartate and glutamate residues are shown as red
spheres.
(TIF)
Figure S5 The DMAPP-bound structure of AfUbiA. (A) A
ribbon representation of the DMAPP-bound AfUbiA structure in
which the thickness of the ribbon indicates the magnitude of the
temperature factor. Residues that are resolved in the DMAPP-
bound structure but disordered in the unliganded structure are
highlighted in red. (B) A cutaway surface of the DMAPP-bound
structure, showing that the central cavity is occluded from the
solvent. (C–D) Stereoviews of the active site in the DMAPP-bound
structure from two orientations. Green mesh corresponds to the
Fo-Fc map calculated with ligand and water molecules omitted,
contoured at 3.0 s.
(TIF)
Figure S6 Ion binding sites in the central cavity. (A) Stereo
view of the active site in the Cd2+-bound structure, viewed from
the cytoplasmic side of the membrane. Yellow spheres
correspond to two Cd2+ atoms, and purple spheres correspond
to the locations of Mg2+ atoms in the GPP-bound structure
when superposed with the Cd2+ structure. Residues that bind to
Mg2+ and the diphosphate are labeled. (B) Stereo view of the
active site from within the plane of the membrane. Conserved
residues predicted to stabilize the intermediate state are labeled.
The green mesh in both figures corresponds to Fo-Fc density
contoured at 4.0 s.
(TIF)
Figure S7 GPP binding to AfUbiA mutant proteins measured by
ITC. (A) Thermograms of four mutant proteins with no detected
GPP binding. (B) Thermograms (top) for two mutant proteins with
measurable affinities for GPP and their corresponding binding
isotherms (bottom). (C) Thermogram of 2 mM GPP injected into
the ITC chamber with no protein present.
(TIF)
Figure S8 EcMenA prenyltransferase assay. (A–B) Membranes
were purified from E. coli overexpressing SUMO-EcMenA or
SUMO-EcUbiA and incubated at 37uC for 10 min with 2 mM
DHNA, 1 mM GPP, and 5 mM MgCl2. The reaction mixtures
were then extracted with chloroform and separated by reverse
phase HPLC. Representative HPLC traces are shown for (A) WT
EcMenA and (B) WT EcUbiA used as a negative control. The
product peak is marked with an arrow. (C) To verify that all
SUMO-EcMenA mutants were overexpressed, 0.5 ml of purified
membrane was run on an SDS-PAGE gel. Lanes marked with
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minus and plus signs indicate whether samples were cleaved with
SUMO protease prior to loading on the gel.
(TIF)
Figure S9 The soluble polyprenyl synthase fold. (A–B) The
structure of a FPPS from E. coli (PDB accession code 1RQI) is
shown from two perpendicular orientations. For consistency with
AfUbiA, the helices are numbered 0–8 and colored according to
the same scheme as in Figure 1C. Orange arrows indicate the two
pseudosymmetric bundles. (C) Two perpendicular views of the
binding pocket of FPPS bound to Mg2+, thioDMAPP, and IPP. In
the left panel, the red asterisk marks the bond that is cleaved in
DMAPP, and the red arrow indicates where a new bond is formed
between IPP and DMAPP.
(TIF)
Figure S10 Electron density in the putative substrate tunnel. (A)
Electron density in the putative substrate channel of AfUbiA in the
experimental maps from the SeMet, unliganded dataset, con-
toured at 1.5 s. (B) Fo-Fc density contoured at 3.0 s in the same
region calculated from the dataset for the GPP-bound structure.
(TIF)
Table S1 Data collection and refinement statistics.
(DOC)
Table S2 Complementation of menA2 E. coli by WT and
mutant EcMenA. OD600 measurements from three experiments of
E. coli cultures grown under anaerobic conditions, used to
calculate the bar graph in Figure 5C.
(DOC)
Table S3 Prenyltransferase activities of WT and mutant
EcMenA. Normalized activities from three experiments with




X-ray diffraction data for this study were collected at beamlines X-29 at the
National Synchrotron Light Source and 17-ID and 24-ID-C & E at the
Advanced Photon Source. We thank Drs. B. Kloss and R. Bruni at the
New York Consortium on Membrane Protein Structure for providing the
initial library of UbiA clones in expression vectors, J. Versalovic for the use
of an anaerobic chamber, and D. Crick for helpful discussions.
Author Contributions
The author(s) have made the following declarations about their
contributions: Conceived and designed the experiments: HH EJL SL YB
SWL MZ. Performed the experiments: HH EJL SL YB. Analyzed the data:
HH EJL SL YB SWL MZ. Wrote the paper: EJL MZ.
References
1. Hirota Y, Tsugawa N, Nakagawa K, Suhara Y, Tanaka K, et al. (2013)
Menadione (vitamin k3) is a catabolic product of oral phylloquinone (vitamin k1)
in the intestine and a circulating precursor of tissue menaquinone-4 (vitamin k2)
in rats. J Biol Chem 288: 33071–33080.
2. Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, et al. (2010)
Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic
enzyme. Nature 468: 117–121.
3. Vos M, Esposito G, Edirisinghe JN, Vilain S, Haddad DM, et al. (2012) Vitamin
K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science 336:
1306–1310.
4. Mugoni V, Postel R, Catanzaro V, De Luca E, Turco E, et al. (2013) Ubiad1 is
an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell
152: 504–518.
5. Orr A, Dube MP, Marcadier J, Jiang H, Federico A, et al. (2007) Mutations in
the UBIAD1 gene, encoding a potential prenyltransferase, are causal for
Schnyder crystalline corneal dystrophy. PLoS ONE 2: e685.
6. Ashby MN, Kutsunai SY, Ackerman S, Tzagoloff A, Edwards PA (1992) COQ2
is a candidate for the structural gene encoding para-hydroxybenzoate:polypre-
nyltransferase. J Biol Chem 267: 4128–4136.
7. Suvarna K, Stevenson D, Meganathan R, Hudspeth ME (1998) Menaquinone
(vitamin K2) biosynthesis: localization and characterization of the menA gene
from Escherichia coli. J Bacteriol 180: 2782–2787.
8. Young IG, Leppik RA, Hamilton JA, Gibson F (1972) Biochemical and genetic
studies on ubiquinone biosynthesis in Escherichia coli K-12:4-hydroxybenzoate
octaprenyltransferase. J Bacteriol 110: 18–25.
9. Oster U, Bauer CE, Rudiger W (1997) Characterization of chlorophyll a and
bacteriochlorophyll a synthases by heterologous expression in Escherichia coli.
J Biol Chem 272: 9671–9676.
10. Saiki K, Mogi T, Ogura K, Anraku Y (1993) In vitro heme O synthesis by the
cyoE gene product from Escherichia coli. J Biol Chem 268: 26041–26044.
11. Hemmi H, Shibuya K, Takahashi Y, Nakayama T, Nishino T (2004) (S)-2,3-Di-
O-geranylgeranylglyceryl phosphate synthase from the thermoacidophilic
archaeon Sulfolobus solfataricus. Molecular cloning and characterization of a
membrane-intrinsic prenyltransferase involved in the biosynthesis of archaeal
ether-linked membrane lipids. J Biol Chem 279: 50197–50203.
12. Yazaki K, Sasaki K, Tsurumaru Y (2009) Prenylation of aromatic compounds, a
key diversification of plant secondary metabolites. Phytochemistry 70: 1739–
1745.
13. Stec E, Li SM (2012) Mutagenesis and biochemical studies on AuaA confirmed
the importance of the two conserved aspartate-rich motifs and suggested
difference in the amino acids for substrate binding in membrane-bound
prenyltransferases. Arch Microbiol 194: 589–595.
14. Collakova E, DellaPenna D (2001) Isolation and functional analysis of
homogentisate phytyltransferase from Synechocystis sp. PCC 6803 and
Arabidopsis. Plant Physiol 127: 1113–1124.
15. Schledz M, Seidler A, Beyer P, Neuhaus G (2001) A novel phytyltransferase
from Synechocystis sp. PCC 6803 involved in tocopherol biosynthesis. FEBS
Lett 499: 15–20.
16. Huang H, Scherman MS, D’Haeze W, Vereecke D, Holsters M, et al. (2005)
Identification and active expression of the Mycobacterium tuberculosis gene
encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-
phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-
d-arabinose synthesis. J Biol Chem 280: 24539–24543.
17. von Heijne G, Gavel Y (1988) Topogenic signals in integral membrane proteins.
Eur J Biochem 174: 671–678.
18. Daley DO, Rapp M, Granseth E, Melen K, Drew D, et al. (2005) Global
topology analysis of the Escherichia coli inner membrane proteome. Science
308: 1321–1323.
19. Cheng W, Li W (2014) Structural insights into ubiquinone biosynthesis in
membranes. Science 343: 878–881.
20. Liang PH (2009) Reaction kinetics, catalytic mechanisms, conformational
changes, and inhibitor design for prenyltransferases. Biochemistry 48: 6562–
6570.
21. Hosfield DJ, Zhang Y, Dougan DR, Broun A, Tari LW, et al. (2004) Structural
basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis. J Biol
Chem 279: 8526–8529.
22. Sasaki K, Mito K, Ohara K, Yamamoto H, Yazaki K (2008) Cloning and
characterization of naringenin 8-prenyltransferase, a flavonoid-specific
prenyltransferase of Sophora flavescens. Plant Physiol 146: 1075–
1084.
23. Brauer L, Brandt W, Schulze D, Zakharova S, Wessjohann L (2008) A structural
model of the membrane-bound aromatic prenyltransferase UbiA from E. coli.
Chembiochem 9: 982–992.
24. Ohara K, Muroya A, Fukushima N, Yazaki K (2009) Functional
characterization of LePGT1, a membrane-bound prenyltransferase involved
in the geranylation of p-hydroxybenzoic acid. Biochem J 421: 231–
241.
25. Shineberg B, Young IG (1976) Biosynthesis of bacterial menaquinones: the
membrane-associated 1,4-dihydroxy-2-naphthoate octaprenyltransferase of
Escherichia coli. Biochemistry 15: 2754–2758.
26. Al-Ghadeer H, Mohamed JY, Khan AO (2011) Schnyder corneal dystrophy in a
Saudi Arabian family with heterozygous UBIAD1 mutation (p.L121F). Middle
East Afr J Ophthalmol 18: 61–64.
27. Jing Y, Liu C, Xu J, Wang L (2009) A novel UBIAD1 mutation identified in a
Chinese family with Schnyder crystalline corneal dystrophy. Mol Vis 15: 1463–
1469.
28. Kobayashi A, Fujiki K, Murakami A, Sugiyama K (2009) In vivo laser confocal
microscopy findings and mutational analysis for Schnyder’s crystalline corneal
dystrophy. Ophthalmology 116: 1029–1037 e1021.
29. Mehta JS, Vithana EN, Venkataraman D, Venkatraman A, Yong VH, et al.
(2009) Surgical management and genetic analysis of a Chinese family with the
S171P mutation in the UBIAD1 gene, the gene for Schnyder corneal dystrophy.
Br J Ophthalmol 93: 926–931.
30. Nickerson ML, Bosley AD, Weiss JS, Kostiha BN, Hirota Y, et al. (2013) The
UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to
cholesterol metabolic enzymes. Hum Mutat 34: 317–329.
Structure of a Membrane-Embedded Prenyltransferase
PLOS Biology | www.plosbiology.org 10 July 2014 | Volume 12 | Issue 7 | e1001911
31. Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, et al. (2010)
UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder
corneal dystrophy. PLoS ONE 5: e10760.
32. Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, Karkera J, et al. (2008) Genetic
analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues
to UBIAD1 protein function. Am J Med Genet A 146: 271–283.
33. Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, White PS, et al. (2007)
Mutations in the UBIAD1 gene on chromosome short arm 1, region 36, cause
Schnyder crystalline corneal dystrophy. Invest Ophthalmol Vis Sci 48: 5007–
5012.
34. Weiss JS, Wiaux C, Yellore V, Raber I, Eagle R, et al. (2010) Newly reported
p.Asp240Asn mutation in UBIAD1 suggests central discoid corneal dystrophy is
a variant of Schnyder corneal dystrophy. Cornea 29: 777–780.
35. Yellore VS, Khan MA, Bourla N, Rayner SA, Chen MC, et al. (2007)
Identification of mutations in UBIAD1 following exclusion of coding mutations
in the chromosome 1p36 locus for Schnyder crystalline corneal dystrophy. Mol
Vis 13: 1777–1782.
36. Ashby MN, Edwards PA (1990) Elucidation of the deficiency in two yeast
coenzyme Q mutants. Characterization of the structural gene encoding
hexaprenyl pyrophosphate synthetase. J Biol Chem 265: 13157–13164.
37. Poulter CD, Argyle JC, Mash EA (1978) Farnesyl pyrophosphate synthetase.
Mechanistic studies of the 19-4 coupling reaction with 2-fluorogeranyl
pyrophosphate. J Biol Chem 253: 7227–7233.
38. Kavanagh KL, Dunford JE, Bunkoczi G, Russell RG, Oppermann U (2006)
The crystal structure of human geranylgeranyl pyrophosphate synthase reveals a
novel hexameric arrangement and inhibitory product binding. J Biol Chem 281:
22004–22012.
39. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, et al. (2012) The Pfam
protein families database. Nucleic Acids Res 40: D290-D301.
40. Yang Y, Miao Y, Wang B, Cui G, Merz KM, Jr. (2012) Catalytic mechanism of
aromatic prenylation by NphB. Biochemistry 51: 2606–2618.
41. Metzger U, Schall C, Zocher G, Unsold I, Stec E, et al. (2009) The structure of
dimethylallyl tryptophan synthase reveals a common architecture of aromatic
prenyltransferases in fungi and bacteria. Proc Natl Acad Sci U S A 106: 14309–
14314.
42. Metzger U, Keller S, Stevenson CE, Heide L, Lawson DM (2010) Structure and
mechanism of the magnesium-independent aromatic prenyltransferase CloQ
from the clorobiocin biosynthetic pathway. J Mol Biol 404: 611–626.
43. Love J, Mancia F, Shapiro L, Punta M, Rost B, et al. (2010) The New York
Consortium on Membrane Protein Structure (NYCOMPS): a high-throughput
platform for structural genomics of integral membrane proteins. J Struct Funct
Genomics 11: 191–199.
44. Caffrey M, Cherezov V (2009) Crystallizing membrane proteins using lipidic
mesophases. Nat Protoc 4: 706–731.
45. Otwinowski Z, Minor W (1997) Processing of X-ray crystallographic data in
oscillation mode. Methods Enzymol 276: 307–326.
46. Grosse-Kunstleve RW, Adams PD (2003) Substructure search procedures for
macromolecular structures. Acta Crystallogr D Biol Crystallogr 59: 1966–1973.
47. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure
solution. Acta Crystallogr D Biol Crystallogr 66: 213–221.
48. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development
of Coot. Acta Crystallogr D Biol Crystallogr 66: 486–501.
49. Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N (2010) ConSurf 2010:
calculating evolutionary conservation in sequence and structure of proteins and
nucleic acids. Nucleic Acids Res 38: W529–W533.
50. Daruwala R, Meganathan R (1991) Dimethyl sulfoxide reductase is not required
for trimethylamine N-oxide reduction in Escherichia coli. FEMS Microbiol Lett
67: 255–259.
Structure of a Membrane-Embedded Prenyltransferase
PLOS Biology | www.plosbiology.org 11 July 2014 | Volume 12 | Issue 7 | e1001911
